O+MEDICALE: what changed
You see two financial years side by side: what moved most in the balance sheet and the result, why the result rose or fell and where the money went.
O+MEDICALE
Largest movements
- Tangible fixed assets -€91,312
down €91,312 (-41.0%), from €222,738 to €131,426
of which Land and buildings: -€90,439
- Deferred charges and accrued income +€26,094
up €26,094 (+46.9%), from €55,596 to €81,690
- Cash +€5,264
up €5,264 (+10.1%), from €52,376 to €57,640
mainly Depreciation (+€91,312) and Accrued charges and deferred income (+€20,694)
- Debts after one year -€89,308
down €89,308 (-70.3%), from €127,026 to €37,718
- Accrued charges and deferred income +€20,694
up €20,694 (+364%), from €5,688 to €26,382
- Profit (loss) carried forward +€15,864
up €15,864 (+291%), from €5,454 to €21,318
- Trade debts -€7,358
down €7,358 (-93.8%), from €7,841 to €483
- Financial income -€2,157
down €2,157 (-82.5%), from €2,614 to €457
- Financial charges -€1,633
down €1,633 (-31.4%), from €5,194 to €3,561
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €355,851 | €296,353 | -€59,498 | -16.7% |
| Fixed assets | 21/28 | €222,875 | €131,563 | -€91,312 | -41.0% |
| Tangible fixed assets | 22/27 | €222,738 | €131,426 | -€91,312 | -41.0% |
| Land and buildings | 22 | €219,632 | €129,193 | -€90,439 | -41.2% |
| Plant, machinery and equipment | 23 | €3,106 | €2,233 | -€873 | -28.1% |
| Financial fixed assets | 28 | €137 | €137 | = | 0.0% |
| Current assets | 29/58 | €132,976 | €164,790 | +€31,814 | +23.9% |
| Amounts receivable within one year | 40/41 | €25,004 | €25,460 | +€456 | +1.8% |
| Other amounts receivable | 41 | €25,004 | €25,460 | +€456 | +1.8% |
| Cash at bank and in hand | 54/58 | €52,376 | €57,640 | +€5,264 | +10.1% |
| Deferred charges and accrued income | 490/1 | €55,596 | €81,690 | +€26,094 | +46.9% |
| Total equity and liabilities | 10/49 | €355,851 | €296,353 | -€59,498 | -16.7% |
| Equity | 10/15 | €76,614 | €92,478 | +€15,864 | +20.7% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Contributions outside capital | 11 | €18,600 | €18,600 | = | 0.0% |
| Other | 1109/19 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €52,560 | €52,560 | = | 0.0% |
| Non-distributable reserves | 130/1 | €52,560 | €52,560 | = | 0.0% |
| Reserves not available under the articles | 1311 | €52,560 | €52,560 | = | 0.0% |
| Profit (loss) carried forward | 14 | €5,454 | €21,318 | +€15,864 | +291% |
| Amounts payable | 17/49 | €279,237 | €203,875 | -€75,362 | -27.0% |
| Amounts payable after more than one year | 17 | €127,026 | €37,718 | -€89,308 | -70.3% |
| Financial debts | 170/4 | €127,026 | €37,718 | -€89,308 | -70.3% |
| Amounts payable within one year | 42/48 | €146,523 | €139,775 | -€6,748 | -4.6% |
| Current portion of amounts payable after more than one year | 42 | €94,846 | €96,673 | +€1,827 | +1.9% |
| Trade debts | 44 | €7,841 | €483 | -€7,358 | -93.8% |
| Suppliers | 440/4 | €7,841 | €483 | -€7,358 | -93.8% |
| Taxes, remuneration and social security | 45 | €2,964 | €1,687 | -€1,277 | -43.1% |
| Remuneration and social security | 454/9 | €2,964 | €1,687 | -€1,277 | -43.1% |
| Other amounts payable | 47/48 | €40,872 | €40,932 | +€60 | +0.1% |
| Accrued charges and deferred income | 492/3 | €5,688 | €26,382 | +€20,694 | +364% |
| Remuneration, social security and pensions | 62 | €22,897 | €23,246 | +€349 | +1.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €90,802 | €91,312 | +€510 | +0.6% |
| Other operating charges | 640/8 | €4,263 | €4,415 | +€152 | +3.6% |
| Gross operating margin | 9900 | €137,693 | €137,941 | +€248 | +0.2% |
| Operating profit (loss) | 9901 | €19,731 | €18,968 | -€763 | -3.9% |
| Financial income | 75/76B | €2,614 | €457 | -€2,157 | -82.5% |
| Recurring financial income | 75 | €2,614 | €457 | -€2,157 | -82.5% |
| Financial charges | 65/66B | €5,194 | €3,561 | -€1,633 | -31.4% |
| Recurring financial charges | 65 | €5,194 | €3,561 | -€1,633 | -31.4% |
| Profit (loss) for the period before taxes | 9903 | €17,151 | €15,864 | -€1,287 | -7.5% |
| Profit (loss) for the period | 9904 | €17,151 | €15,864 | -€1,287 | -7.5% |
| Profit (loss) for the period to be appropriated | 9905 | €17,151 | €15,864 | -€1,287 | -7.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.